Back to Search
ELLEN WEISBERG, PH.D.
PH.D.
Developmental Therapist
NPI: 1083968366Individual
Specialties, Licenses & Credentials
Developmental TherapistPrimary
Developmental Therapist
Code: 222Q00000X
Research & Publications (20)
FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML.
PMID 19467916·Drug Resist Updat·2009
6-review
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.
PMID 18445657·Mol Cancer Ther·2008
7-preclinical
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells.
PMID 18820131·Blood·2008
7-preclinical
A case of simultaneously occurring lichen sclerosus and segmental vitiligo: connecting the underlying autoimmune pathogenesis.
PMID 18986354·Int J Dermatol·2008
5-case
Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.
PMID 18184863·Blood·2008
7-preclinical
Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias.
PMID 17068153·Blood·2007
7-preclinical
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells.
PMID 17620426·Mol Cancer Ther·2007
7-preclinical
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia.
PMID 17457302·Nat Rev Cancer·2007
6-review
AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL.
PMID 16721371·Br J Cancer·2006
6-review
Effects of PKC412, nilotinib, and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity.
PMID 17087936·Gastroenterology·2006
7-preclinical
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.
PMID 15710326·Cancer Cell·2005
7-preclinical
Histone deacetylase inhibitor NVP-LAQ824 has significant activity against myeloid leukemia cells in vitro and in vivo.
PMID 15496979·Leukemia·2004
7-preclinical
Resistance to imatinib (Glivec): update on clinical mechanisms.
PMID 14643293·Drug Resist Updat·2003
6-review
Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.
PMID 12124173·Cancer Cell·2002
7-preclinical
Mechanisms of resistance imatinib (STI571) in preclinical models and in leukemia patients.
PMID 11512149·Drug Resist Updat·2001
6-review
Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines.
PMID 10828035·Blood·2000
7-preclinical
Does readily available emergency contraception increase women's awareness and use?
PMID 19241300·Eur J Contracept Reprod Health Care·2009
8-other
A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users.
PMID 19369294·Hum Reprod·2009
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 321 FORTUNE BLVD
MILFORD, MA 01757 - Phone
- (508) 478-0207
Quick Facts
- NPI
- 1083968366
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile